Dose modifications and pharmacokinetics of adjuvant cisplatin monotherapy while on hemodialysis for patients with hepatoblastoma-Reference-Cited by-同舟云学术

Dose modifications and pharmacokinetics of adjuvant cisplatin monotherapy while on hemodialysis for patients with hepatoblastoma

Author:

Boucher Alexander A.¹^ORCID,Mizuno Tomoyuki²^ORCID,Vinks Alexander A.²³,Goldstein Stuart L.³⁴,Tiao Greg M.³⁵,Geller James I.¹³^ORCID

Affiliation:

1. Division of Oncology, Cancer and Blood Diseases Institute; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

2. Division of Clinical Pharmacology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

3. Department of Pediatrics; University of Cincinnati College of Medicine; Cincinnati Ohio

4. Division of Nephrology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

5. Division of Pediatric General and Thoracic Surgery; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

Reference21 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Cisplatin;Reactions Weekly;2019-01